---
title: Clario vs Fortrea
slug_a: clario
slug_b: fortrea
site: cro
review_signal_gate: closed
canonical_path: /compare/clario/fortrea
generated_by: BioBM Editorial AI
---

# Clario vs Fortrea

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Clario (clario) is listed for cro. Clario provides comprehensive clinical trial endpoint solutions spanning cardiac safety, eCOA, medical imaging, respiratory, and precision motion analysis, supporting approximately 70% of FDA and EMA novel drug approvals over the past decade.

Services: 16. Modalities: 4. Indications: 12. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (16).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Fortrea (fortrea) is listed for cro. Fortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.

Services: 17. Modalities: 6. Indications: 13. Locations: 54. Certifications: 2. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (54).

Review summary: Review summary withheld until site-level review gate opens.